Company
Every investor coverage indicates participated in a round BioPak raised.
Investors whose own portfolio pages list BioPak, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Five V Capital | its portfolio page ↗ |
Companies BioPak acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Gary Smith | CEO | @AuManufacturing, Coterie Capital, Forbes Australia |
Stories naming BioPak. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Manufacturing roundup: Noizend's grants and UTS work, PPK's planned Li-S share distribution, a Bathurst recycling trial, Aurecon's CETRI role, an ELA regulatory hire, BioPak's OzHarvest support, and ANSTO's reactor restart.
Coterie Capital says it has cashed out its Huskee stake after the cup maker's sale to Five V-backed BioPak, with bosses at all three companies calling the deal a sustainability win.
Compostable packaging maker BioPak is entering Hong Kong before its plastic ban; the profile recalls Five V's 2022 $65.8 million stake at a $275 million valuation and flags possible acquisitions.